Initiates Coverage on Retractable Technologies (NYSE:RVP) began coverage on shares of Retractable Technologies (NYSE:RVPGet Rating) in a note issued to investors on Thursday. The brokerage set a “buy” rating on the stock.

Retractable Technologies Stock Up 1.8 %

Retractable Technologies stock traded up $0.04 during trading hours on Thursday, hitting $2.32. The company had a trading volume of 25,870 shares, compared to its average volume of 37,633. The firm has a market cap of $76.42 million, a PE ratio of 2.64 and a beta of 2.10. The company has a debt-to-equity ratio of 0.01, a quick ratio of 4.89 and a current ratio of 6.12. Retractable Technologies has a fifty-two week low of $1.90 and a fifty-two week high of $9.11.

About Retractable Technologies

(Get Rating)

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. It offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.

Recommended Stories

Receive News & Ratings for Retractable Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Retractable Technologies and related companies with's FREE daily email newsletter.